Acadia Pharmaceuticals ACAD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $3.64M-98.7% | $273.57M+281% | $71.78M+169% | $26.67M+40.4% | $18.99M-86.8% | ||
| $271K+34.2% | $202K-11.0% | $227K+6.6% | $213K-7.0% | $229K+1.3% | ||
| $14.7M+11.1% | $13.24M+0.4% | $13.18M-8.1% | $14.34M+26.0% | $11.38M+8.9% | ||
| $33.98M— | —— | $74.29M+16.2% | $63.96M+215% | $20.32M-49.7% | ||
| $5.21M+30.1% | $4.01M+932% | $388K+30.6% | $297K— | $0-100% | ||
| $66.28M+219% | -$55.87M+29.6% | -$79.35M-83.3% | -$43.29M+65.1% | -$124.05M— | ||
| $4.23M-81.3% | $22.67M+141% | $9.42M-40.9% | $15.96M+768% | $1.84M-6.7% | ||
| $104.52M+228% | -$81.93M— | —— | —— | -$101.89M-162% | ||
| $28.77M— | —— | $73.9M+16.1% | $63.66M+213% | $20.32M-49.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Acadia Pharmaceuticals generate?
- Acadia Pharmaceuticals (ACAD) generated $192.5M in operating cash flow over the trailing twelve months.
- What is Acadia Pharmaceuticals's free cash flow?
- After $9.9M of capital expenditures, Acadia Pharmaceuticals's free cash flow was $186.7M over the trailing twelve months, up 13.4% year over year.
- Where does Acadia Pharmaceuticals's cash flow data come from?
- Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
